Leishmaniasis is a disease of the subtropical and tropical spheres of the earth and has
various clinical manifestations. The different form of leishmaniasis includes cutaneous …

Ninety per cent of the 500 000 annual new cases of visceral leishmaniasis (VL) occur in
India/Bangladesh/Nepal, Sudan and Brazil. Importantly, 80–90% of human infections are …

Leishmaniases remain a major public health problem today despite the vast amount of
research conducted on Leishmania pathogens. The biological model is genetically and …

Two important recent advances in Leishmania immunology are:(i) the demonstration of a
dramatic dichotomy in T helper 1 versus T helper 2 subset expansion leading to protection …

Objectives To investigate the association between selected single nucleotide
polymorphisms (SNPs) in TNF, LTA and SLC11A1 genes and risk of endemic cutaneous …

Identifying genetic risk factors for parasitic infections such as the leishmaniases could
provide important leads for improved therapies and vaccines. Until recently most genetic …

Molecular approaches are being used increasingly for epidemiological studies of visceral
and cutaneous leishmaniases. Several molecular markers resolving genetic differences …

The polymorphism and genetic diversity of Leishmania genus has status under discussion
depending on many items such as nuclear and/or mitochondrial genes, molecular tools …

Protozoan parasites of the genus Leishmania are responsible of a large variety of clinical
manifestations ranging from self-healing cutaneous forms (CL), through mucocutaneous …

Leishmaniasis is one of the world's important infectious diseases. It is prevalent in tropical
and subtropical regions of the world and endemic in 88 countries, with two million new …